关注风湿病的“多病共存”研究(4)
[17]MOHAMMAD AJ，ENGLUND M，TURESSON C，et al.Rate of Comorbidities in Giant Cell Arteritis：A Population-based Study[J].J Rheumatol，2017，44(1)：84-90.
[18]CHUANG MH，CHUANG YL，HUANG KY，et al.Age-adjusted Charlson Comorbidity Index scores predict major adverse cardiovascular events and allcause mortality among systemic lupus erythematosus patients[J].Ci Ji Yi Xue Za Zhi，2017，29(3)：154-158.
[19]KIM SK，CHOE JY，LEE SS.Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus：Data from KORean lupus Network (KORNET)Registry[J].J Rheumatol，2017，44(4)：452-458.
[20]NAZ SM，SYMMONS DP.Mortality in established rheumatoid arthritis[J].Best Pract Res Clin Rheumatol，2007，21(5)：871-883.
[21]RADNER H，SMOLEN JS，ALETAHA D.Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis[J].Rheumatology(Oxford)，2010，50(2)：381-388.
[22]RADNER H，YOSHIDA K，FRITS M，et al.The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs[J].Rheumatology，2015，54(11)：2076-2084.
[23]PAREKH AK，BARTON MB.The Challenge of Multiple Comorbidity for the US Health Care System[J].JAMA，2010，303(13)：1303-1304., 百拇医药(李振彬)
[18]CHUANG MH，CHUANG YL，HUANG KY，et al.Age-adjusted Charlson Comorbidity Index scores predict major adverse cardiovascular events and allcause mortality among systemic lupus erythematosus patients[J].Ci Ji Yi Xue Za Zhi，2017，29(3)：154-158.
[19]KIM SK，CHOE JY，LEE SS.Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus：Data from KORean lupus Network (KORNET)Registry[J].J Rheumatol，2017，44(4)：452-458.
[20]NAZ SM，SYMMONS DP.Mortality in established rheumatoid arthritis[J].Best Pract Res Clin Rheumatol，2007，21(5)：871-883.
[21]RADNER H，SMOLEN JS，ALETAHA D.Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis[J].Rheumatology(Oxford)，2010，50(2)：381-388.
[22]RADNER H，YOSHIDA K，FRITS M，et al.The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs[J].Rheumatology，2015，54(11)：2076-2084.
[23]PAREKH AK，BARTON MB.The Challenge of Multiple Comorbidity for the US Health Care System[J].JAMA，2010，303(13)：1303-1304., 百拇医药(李振彬)